ENA Respiratory Pty

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, ENA Respiratory Pty sits in the upper half of US sponsors by registered trial count (#7,388 of 15,742 sponsors by registered trial count).

1 total trials 1 currently recruiting early-phase tilt upper half by trial count

ENA Respiratory Pty: 1 sponsored US clinical trial, 1 recruiting.

ENA Respiratory Pty sponsors 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Viral Respiratory Illnesses, with 1 trials.

Mid-pack sponsor footprint

ENA Respiratory Pty is in the upper half of sponsors by trial count (#7,388 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

What is open in the ENA Respiratory Pty pipeline

1 recruiting of 1 indexed (100% open).

Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).

Top condition: Viral Respiratory Illnesses (1 trial), 1 other listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

ENA Respiratory Pty: open-pipeline peers nationwide

Peers matched on 1 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

ENA Respiratory Pty sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 012345 0%50%100%150% Total trials Recruiting share ENA Respiratory Pty1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO HealthAAVantgarde Bio SrlAcorn BiolabsAcrivon TherapeuticsADARx Pharmaceuticals
ENA Respiratory Pty sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

ENA Respiratory Pty sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1 trials (± recruiting share)

Sponsors near 100% open enrollment (± trial volume)

What to do with this ENA Respiratory Pty page

1 registered trials is a research-attention snapshot, not an endorsement of ENA Respiratory Pty or any single study.

  • 1 of ENA Respiratory Pty's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Viral Respiratory Illnesses is the condition ENA Respiratory Pty studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Viral Respiratory Illnesses trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

ENA Respiratory Pty pipeline card: 1 registered trials from official public datasets.Report a data error.